Top News

Plaintiffs allege cancer drug Taxotere causes permanent hair loss, sue manufacturer

Chandra Lye Jul. 15, 2017, 12:00pm

The first case in multi-district litigation (MDL) revolving around permanent hair loss from a breast cancer drug has been set for trial in September 2018.

Aventis Pharma et al allegedly failed to warn cancer patients of Taxotere's side effects

The Louisiana Record Oct. 11, 2016, 11:22pm

NEW ORLEANS — A breast cancer patient has filed suit against three drug manufacturing companies for alleged design defect, failure to warn and breach of express warranty.